Dechra Regulatory B.V has issued a class III recall to the wholesale level.

The product has been manufactured according to the specifications of Dutch marketing authorisation.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall for all in-date batches of Clindacutin Ointment 10mg/g.

In a news release, the VMD writes: “We wish to make wholesalers and distributors aware that all in-date batches of Clindacutin Ointment 10 mg/g (Vm 50406/4011) are being recalled with immediate effect.

“Dechra Regulatory B.V has issued a class III recall to the wholesale level.

“The reason for the recall is that the product has been manufactured released according to specifications of the Dutch marketing authorisation which is not approved in this country.” 

The recall is for the following batches only BC (21H258) expiry date July 2023, and BB (21H244) expiry date July 2023.

Dechra Regulatory B.V is contacting wholesale dealers to examine inventory immediately and quarantine any products subject to recall. 

For more information please contact quality@dechra.com or externalnetwork.qa@dechra.com